| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |


*
Department of Medicine, University of Michigan, Ann Arbor,
Michigan.
Department of Biostatistics, University of Michigan, Ann Arbor,
Michigan.
Department of Epidemiology, University of Michigan, Ann Arbor,
Michigan.
§
The United States Renal Data System, Division of Kidney, Urologic, and
Hematologic Diseases, National Institute of Diabetes and Digestive and Kidney
Diseases, National Institutes of Health, Bethesda, Maryland.
Correspondence to Dr. Akinlolu O. Ojo, Division of Nephrology, TC 3914, Box 0364, Department of Internal Medicine, The University of Michigan Medical Center, Ann Arbor, MI 48109-0364. Phone: 734-763-9041; Fax: 734-936-9621; E-mail: aojo{at}umich.edu
Abstract. An increasing number of cadaveric kidney transplants are now performed with organs from donors who would have been deemed unsuitable in earlier times. Although good allograft outcomes have been obtained with these marginal donor transplants, it is unclear whether recipients of marginal kidney transplants achieve a reduction in long-term mortality as do recipients of "ideal" kidneys. Patients with end-stage renal disease registered on the cadaveric renal transplant waiting list between January 1, 1992, and June 30, 1997, were studied for mortality risks according to three outcomes: wait-listed on dialysis treatment with no transplant (WLD); transplantation with marginal donor kidney (MDK); and "ideal" or optimal donor kidney transplantation (IDK). Thirty-four percent of wait-list registrants had received a cadaveric kidney transplant by June 30, 1998. Of these, 18% received a marginal kidney that had one or more of the following pretransplant factors: donor age >55 yr, non-heartbeating donor, cold ischemia time >36 h, and donor hypertension or diabetes mellitus of > 10 yr duration. Five-year graft and patient survival was 53% and 74% for MDK recipients compared with 67% (P < 0.001) and 80% (P < 0.001) for IDK recipients. Adjusted annual death rate and estimated remaining life time was 6.3%, 4.7%, and 3.3% and 15.3 yr, 20.4 yr, and 28.7 yr for WLD, MDK, and IDK groups, respectively. The average increase in life expectancy for MDK recipients compared with the WLD cohort was 5 yr, although this benefit varied from 3 to 10 yr depending on the recipient's characteristics. It is concluded that transplantation of a marginal kidney is associated with a significant survival benefit when compared with maintenance dialysis.
This article has been cited by other articles:
![]() |
W. Bentas, J. Jones, A. Karaoguz, U. Tilp, M. Probst, E. Scheuermann, I. A. Hauser, D. Jonas, and J. Gossmann Renal transplantation in the elderly: surgical complications and outcome with special emphasis on the Eurotransplant Senior Programme Nephrol. Dial. Transplant., June 1, 2008; 23(6): 2043 - 2051. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Delahousse, M. Chaignon, L. Mesnard, P. Boutouyrie, M. E. Safar, T. Lebret, M. Pastural-Thaunat, L. Tricot, A. Kolko-Labadens, A. Karras, et al. Aortic Stiffness of Kidney Transplant Recipients Correlates with Donor Age J. Am. Soc. Nephrol., April 1, 2008; 19(4): 798 - 805. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Arns, F. Citterio, and J. M. Campistol 'Old-for-old'--new strategies for renal transplantation Nephrol. Dial. Transplant., February 1, 2007; 22(2): 336 - 341. [Full Text] [PDF] |
||||
![]() |
M. A. Josephson Rabbit Antithymocyte Globulin or Basiliximab for Induction Therapy? N. Engl. J. Med., November 9, 2006; 355(19): 2033 - 2035. [Full Text] [PDF] |
||||
![]() |
A. J. Matas Why We Should Develop a Regulated System of Kidney Sales: A Call for Action! Clin. J. Am. Soc. Nephrol., November 1, 2006; 1(6): 1129 - 1132. [Full Text] [PDF] |
||||
![]() |
P. P. Reese, A. L. Caplan, A. S. Kesselheim, and R. D. Bloom Creating a Medical, Ethical, and Legal Framework for Complex Living Kidney Donors Clin. J. Am. Soc. Nephrol., November 1, 2006; 1(6): 1148 - 1153. [Full Text] [PDF] |
||||
![]() |
D. J. Kutsogiannis, G. Pagliarello, C. Doig, H. Ross, and S. D. Shemie Medical management to optimize donor organ potential: review of the literature: [Traitement medical pour optimaliser le potentiel de don d'organe : une revue documentaire]. Can J Anesth, August 1, 2006; 53(8): 820 - 830. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. I. Sanchez-Fructuoso, M. Marques, D. Prats, J. Conesa, N. Calvo, M. J. Perez-Contin, J. Blazquez, C. Fernandez, E. Corral, F. Del Rio, et al. Victims of cardiac arrest occurring outside the hospital: a source of transplantable kidneys. Ann Intern Med, August 1, 2006; 145(3): 157 - 164. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Goldfarb-Rumyantzev, J. F. Hurdle, B. C. Baird, G. Stoddard, Z. Wang, J. D. Scandling, L. L. Barenbaum, and A. K. Cheung The role of pre-emptive re-transplant in graft and recipient outcome Nephrol. Dial. Transplant., May 1, 2006; 21(5): 1355 - 1364. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Goldfarb-Rumyantzev, L. Smith, F. S. Shihab, B. C. Baird, A. N. Habib, S.-j. Lin, and L. L. Barenbaum Role of Maintenance Immunosuppressive Regimen in Kidney Transplant Outcome Clin. J. Am. Soc. Nephrol., May 1, 2006; 1(3): 563 - 574. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Goldfarb-Rumyantzev, J. K. Koford, B. C. Baird, M. Chelamcharla, A. N. Habib, B.-J. Wang, S.-j. Lin, F. Shihab, and R. B. Isaacs Role of Socioeconomic Status in Kidney Transplant Outcome Clin. J. Am. Soc. Nephrol., March 1, 2006; 1(2): 313 - 322. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kandus, M. Arnol, and A. F. Bren Renal transplantation in Slovenia after joining Eurotransplant Nephrol. Dial. Transplant., January 1, 2006; 21(1): 36 - 39. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Merion, V. B. Ashby, R. A. Wolfe, D. A. Distant, T. E. Hulbert-Shearon, R. A. Metzger, A. O. Ojo, and F. K. Port Deceased-Donor Characteristics and the Survival Benefit of Kidney Transplantation JAMA, December 7, 2005; 294(21): 2726 - 2733. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Knoll, S. Cockfield, T. Blydt-Hansen, D. Baran, B. Kiberd, D. Landsberg, D. Rush, E. Cole, and for The Kidney Transplant Working Group of the Can Canadian Society of Transplantation: consensus guidelines on eligibility for kidney transplantation Can. Med. Assoc. J., November 8, 2005; 173(10): S1 - S25. [Full Text] [PDF] |
||||
![]() |
F. Otero-Ravina, M. Rodriguez-Martinez, F. Gude, J. R. Gonzalez-Juanatey, F. Valdes, and D. Sanchez-Guisande Renal transplantation in the elderly: does patient age determine the results? Age Ageing, November 1, 2005; 34(6): 583 - 587. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. de Fijter and G. G. Persijn Age, the riddle of renal transplantation Nephrol. Dial. Transplant., November 1, 2005; 20(11): 2307 - 2310. [Full Text] [PDF] |
||||
![]() |
A. J. Matas and D. E. R. Sutherland The Importance of Innovative Efforts to Increase Organ Donation JAMA, October 5, 2005; 294(13): 1691 - 1693. [Full Text] [PDF] |
||||
![]() |
J. D. Schold, B. Kaplan, N. R. Chumbler, R. J. Howard, T. R. Srinivas, L. Ma, and H.-U. Meier-Kriesche Access to Quality: Evaluation of the Allocation of Deceased Donor Kidneys for Transplantation J. Am. Soc. Nephrol., October 1, 2005; 16(10): 3121 - 3127. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Schaubel and J. Cai Analysis of clustered recurrent event data with application to hospitalization rates among renal failure patients Biostat., July 1, 2005; 6(3): 404 - 419. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Magee and M. Pascual Update in Renal Transplantation Arch Intern Med, July 12, 2004; 164(13): 1373 - 1388. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. Morrissey, R. Gohh, A. Yango, A. Gautam, and A. P. Monaco Renal Transplant Survival From Older Donors: A Single Center Experience Arch Surg, April 1, 2004; 139(4): 384 - 389. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Keith, A. Demattos, M. Golconda, J. Prather, and D. Norman Effect of Donor Recipient Age Match on Survival after First Deceased Donor Renal Transplantation J. Am. Soc. Nephrol., April 1, 2004; 15(4): 1086 - 1091. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Abbott, J. R. Bucci, C. S. Matsumoto, S. J. Swanson, L. Y.C. Agodoa, K. C. Holtzmuller, D. F. Cruess, and T. G. Peters Hepatitis C and Renal Transplantation in the Era of Modern Immunosuppression J. Am. Soc. Nephrol., November 1, 2003; 14(11): 2908 - 2918. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bunnapradist, H. A. Gritsch, A. Peng, S. C. Jordan, and Y. W. Cho Dual Kidneys from Marginal Adult Donors as a Source For Cadaveric Renal Transplantation in the United States J. Am. Soc. Nephrol., April 1, 2003; 14(4): 1031 - 1036. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gourishankar, G. S. Jhangri, S. M. Cockfield, and P. F. Halloran Donor Tissue Characteristics Influence Cadaver Kidney Transplant Function and Graft Survival but Not Rejection J. Am. Soc. Nephrol., February 1, 2003; 14(2): 493 - 499. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Bucci, C. S. Matsumoto, S. J. Swanson, L. Y. C. Agodoa, K. C. Holtzmuller, T. G. Peters, and K. C. Abbott Donor Hepatitis C Seropositivity: Clinical Correlates and Effect on Early Graft and Patient Survival in Adult Cadaveric Kidney Transplantation J. Am. Soc. Nephrol., December 1, 2002; 13(12): 2974 - 2982. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Cecka Donors without a Heartbeat N. Engl. J. Med., July 25, 2002; 347(4): 281 - 283. [Full Text] [PDF] |
||||
![]() |
S. D. Halpern, P. A. Ubel, and A. L. Caplan Solid-Organ Transplantation in HIV-Infected Patients N. Engl. J. Med., July 25, 2002; 347(4): 284 - 287. [Full Text] [PDF] |
||||
![]() |
G. M. Danovitch, S. Hariharan, J. D. Pirsch, D. Rush, D. Roth, E. Ramos, R. C. Starling, C. Cangro, and M. R. Weir Management of the Waiting List for Cadaveric Kidney Transplants: Report of a Survey and Recommendations by the Clinical Practice Guidelines Committee of the American Society of Transplantation J. Am. Soc. Nephrol., February 1, 2002; 13(2): 528 - 535. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Piillips, S. J. Davies, and E. White Health-related quality of life assessment in end-stage renal failure Journal of Research in Nursing, May 1, 2001; 6(3): 658 - 670. [Abstract] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673